LCRF News: August 2022



Give Wings to Research on WLCD – Sign Up and Download a Free Kit at

It’s not just for August – you can sign up to participate at any time.

#TogetherSeparately Monthly Livestreams & Facebook Group

LCRF hosts webinars to bring the lung cancer community together to discuss topics important to them. Find out more and register for an upcoming livestream. The community also has a lively and engaged Facebook group.

#TogetherSeparately: Surviving Survivorship

August 17 @ 3:30 pm – 5:00 pm EDT

Dr. Isabel Preeshagul will be joined by Dr. Marleen Meyers and Jill Feldman for our Lung Cancer Community Talk on Wednesday, August 17 at a special time of 3:30 PM ET. This livestream is an opportunity to connect face-to-face with others who care about lung cancer and talk about challenges we’re facing, #TogetherSeparately. We hope you’ll join us for this important discussion on survivorship – we’ll talk through ways to manage physical and emotional side effects, including coping with anxiety and fear, and discuss social and financial challenges that may arise following cancer treatment.

Register at:

Stay on after the survivorship panel for a special Free to Breathe Walk Happy Hour! Grab a drink or snack and join us from 4:30-5 pm EST for a casual gathering to learn more about LCRF’s walk event and ways that YOU can help move lung cancer research forward. It will be a fun event, complete with contests and raffle prizes, and stories from patients who have participated in the walk in the past.

LCRF updates its Comprehensive Biomarker Testing educational resource, now available for download:

You do not need to be a doctor to understand your tumor. Biomarker testing can help.

When your doctors suspected you had cancer, they took a small portion of your tumor tissue (a biopsy) to have it examined. A specialist, called a pathologist, looked at your tumor cells under the microscope and found out you had lung cancer. There are two main types of lung cancer–small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC). If you have NSCLC, the pathologist looks closely at the cancer cells for certain characteristics (features or qualities). Tumors with similar characteristics are referred to as subtypes. Adenocarcinoma (A-deh-noh-KAR-sih-NOH-muh) and squamous cell carcinoma (SKWAY-mus sel KAR-sih-NOH-muh) are the most common subtypes of NSCLC. Once your health care team knows the subtype of your cancer, treatment planning can begin. Read more & download your copy at

LCRF’s Summer eNews is Available:

Included in this issue:

LCRF Welcomes New Scientific Advisory Board Members

LCRF Creates Scientific Executive Committee

LCRF Welcomes New Board Member

And more!